Lewis-Rogers Nicole, Seger Jon, Adler Frederick R
Department of Biology, University of Utah, Salt Lake City, Utah, USA
Department of Biology, University of Utah, Salt Lake City, Utah, USA.
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.01659-16. Print 2017 Apr 1.
Rhinoviruses are the most common causes of the common cold. Their many distinct lineages fall into "major" and "minor" groups that use different cell surface receptors to enter host cells. Minor-group rhinoviruses are more immunogenic in laboratory studies, although their patterns of transmission and their cold symptoms are broadly similar to those of the major group. Here we present evolutionary evidence that minor-group viruses are also more immunogenic in humans. A key finding is that rates of amino acid substitutions at exposed sites in the capsid proteins VP2, VP3, and VP1 tend to be elevated in minor-group relative to major-group viruses, while rates at buried sites show no consistent differences. A reanalysis of historical virus watch data also indicates a higher immunogenicity of minor-group viruses, consistent with our findings about evolutionary rates at amino acid positions most directly exposed to immune surveillance. The increased immunogenicity and speed of evolution in minor-group lineages may contribute to the very large numbers of rhinovirus serotypes that coexist while differing in virulence. Most colds are caused by rhinoviruses (RVs). Those caused by a subset known as the minor-group members of rhinovirus species A (RV-A) are correlated with the inception and aggravation of asthma in at-risk populations. Genetically, minor-group viruses are similar to major-group RV-A, from which they were derived, although they tend to elicit stronger immune responses. Differences in their rates and patterns of molecular evolution should be highly relevant to their epidemiology. All RV-A strains show high rates of amino acid substitutions in the capsid proteins at exposed sites not previously identified as being immunogenic, and this increase is significantly greater in minor-group viruses. These findings will inform future studies of the recently discovered RV-C, which also appears to exacerbate asthma in adults and children. In addition, these findings draw attention to the difficult problem of explaining the long-term coexistence of many serotypes of major- and minor-group RVs.
鼻病毒是普通感冒最常见的病因。它们众多不同的谱系可分为“主要”和“次要”组,这两组使用不同的细胞表面受体进入宿主细胞。在实验室研究中,次要组鼻病毒具有更强的免疫原性,尽管它们的传播模式和感冒症状与主要组大致相似。在此,我们提供了进化证据,表明次要组病毒在人类中也具有更强的免疫原性。一个关键发现是,相对于主要组病毒,次要组病毒衣壳蛋白VP2、VP3和VP1暴露位点的氨基酸替换率往往更高,而埋藏位点的替换率则没有一致的差异。对历史病毒监测数据的重新分析也表明次要组病毒具有更高的免疫原性,这与我们关于最直接暴露于免疫监视的氨基酸位置进化率的发现一致。次要组谱系中免疫原性和进化速度的增加可能导致大量共存但毒力不同的鼻病毒血清型的出现。大多数感冒是由鼻病毒(RVs)引起的。由鼻病毒A种(RV-A)的一个子集即次要组成员引起的感冒与高危人群哮喘的发作和加重相关。从基因上看,次要组病毒与它们所衍生的主要组RV-A相似,尽管它们往往会引发更强的免疫反应。它们分子进化的速率和模式差异应该与其流行病学高度相关。所有RV-A毒株在衣壳蛋白的暴露位点都显示出高氨基酸替换率,这些位点以前未被确定为具有免疫原性,而且这种增加在次要组病毒中更为显著。这些发现将为最近发现的RV-C的未来研究提供参考,RV-C似乎也会加重成人和儿童的哮喘。此外,这些发现还引发了人们对解释主要组和次要组RVs多种血清型长期共存这一难题的关注。